4//SEC Filing
Gordon Gary B. 4
Accession 0000899243-22-000879
CIK 0001797336other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:05 PM ET
Size
5.4 KB
Accession
0000899243-22-000879
Insider Transaction Report
Form 4
Gordon Gary B.
Chief Medical Officer
Transactions
- Award
Stock Option
2022-01-03+31,950→ 31,950 totalExercise: $9.11Exp: 2032-01-02→ Common Stock (31,950 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in sixteen substantially equal quarterly installments following the grant date, such that the option shall be fully vested on January 3, 2026.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
Related Parties
1- filerCIK 0001811354
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:05 PM ET
- Size
- 5.4 KB